...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Not adding up!

FWIW, there is no talk in calgary about either Zenith or RVX. Seems like the interest  in them have withered away. Either no one cares or no one believes. I could tell you what they do care about now but my post would just get deleted

Share
New Message
Please login to post a reply